Status:
RECRUITING
The Olmsted NAFLD Epidemiology Study (TONES)
Lead Sponsor:
Mayo Clinic
Conditions:
Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Steatohepatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults wit...
Detailed Description
Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. Recent information on the prevalence of NAFLD in gen...
Eligibility Criteria
Inclusion
- Olmsted County residents at the time of search
- Age 18 or older
- No personal history of NAFLD diagnosis (administrative codes)
Exclusion
- Alcohol in excess (more than 20 gm per week in women and 30 gm per week in men)
- Currently pregnant
- Have contraindications to MRI (MRI incompatible implanted devices, severe claustrophobia)
Key Trial Info
Start Date :
September 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04365855
Start Date
September 29 2020
End Date
June 1 2028
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905